Get started
Author

Xionghua Wu

The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials
2013 · G De Serres, D M Skowronski, et al. · Eurosurveillance · 247
PDF
Cardiopulmonary Exercise Testing and Six-Minute Walk Correlations in Pulmonary Arterial Hypertension
2005 · Ronald J. Oudiz, Robyn J. Barst, et al. · The American Journal of Cardiology · 157
Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity
2009 · Robert B. Belshe, Kathleen Coelingh, et al. · Vaccine · 145
The role of nasal IgA in children vaccinated with live attenuated influenza vaccine
2012 · Christopher S. Ambrose, Xionghua Wu, et al. · Vaccine · 115
The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies
2011 · Christopher S. Ambrose, Xionghua Wu, et al. · Vaccine · 97
Respiratory Syncytial Virus Disease in Preterm Infants in the US Born at 32–35 Weeks Gestation Not Receiving Immunoprophylaxis
2013 · Christopher S. Ambrose, Evan J. Anderson, et al. · The Pediatric Infectious Disease Journal · 89
Distribution of Respiratory Syncytial Virus Subtypes A and B Among Infants Presenting to the Emergency Department With Lower Respiratory Tract Infection or Apnea
2013 · Hasan S. Jafri, Xionghua Wu, et al. · The Pediatric Infectious Disease Journal · 76
High response rate and PFS with PEGPH20 added to nab-paclitaxel/gemcitabine in stage IV previously untreated pancreatic cancer patients with high-HA tumors: Interim results of a randomized phase II study.
2015 · Sunil R. Hingorani, William Proctor Harris, et al. · Journal of Clinical Oncology · 59
The Efficacy of Live Attenuated and Inactivated Influenza Vaccines in Children as a Function of Time Postvaccination
2010 · Christopher S. Ambrose, Xionghua Wu, et al. · The Pediatric Infectious Disease Journal · 55
Effectiveness of Intranasal Live Attenuated Influenza Vaccine Against All-cause Acute Otitis Media in Children
2012 · Terho Heikkinen, Stan L. Block, et al. · The Pediatric Infectious Disease Journal · 43
Randomized phase II study of PEGPH20 plus nab-paclitaxel/gemcitabine (PAG) vs AG in patients (Pts) with untreated, metastatic pancreatic ductal adenocarcinoma (mPDA).
2017 · Sunil R. Hingorani, Andrea J. Bullock, et al. · Journal of Clinical Oncology · 34
Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants
2014 · Michael L Forbes, Veena R Kumar, et al. · Human Vaccines & Immunotherapeutics · 34
PDF
The Underrecognized Burden of Respiratory Syncytial Virus Among Infants Presenting to US Emergency Departments
2014 · Doris Makari, Mary Allen Staat, et al. · Clinical Pediatrics · 32
PDF
A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age
2012 · Roger Baxter, Seth L. Toback, et al. · Vaccine · 31
PDF
A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18–49 years of age
2012 · Roger Baxter, Seth L. Toback, et al. · Vaccine · 29
PDF
Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation
2016 · Eric A. F. Simões, Evan J. Anderson, et al. · PLoS ONE · 27
PDF
Interim results of a randomized phase II study of PEGPH20 added to nab-paclitaxel/gemcitabine in patients with stage IV previously untreated pancreatic cancer.
2016 · Sunil R. Hingorani, William Proctor Harris, et al. · Journal of Clinical Oncology · 26
A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24–59 months of age
2013 · Seth L. Toback, Christopher S. Ambrose, et al. · Vaccine · 26
The safety and effectiveness of self-administration of intranasal live attenuated influenza vaccine in adults
2012 · Christopher S. Ambrose, Xionghua Wu · Vaccine · 25
Respiratory syncytial virus-related hospitalization in premature infants without bronchopulmonary dysplasia: subgroup efficacy analysis of the IMpact-RSV trial by gestational age group
2014 · Gerard Waycaster, Pamela Vo, et al. · Pediatric Health Medicine and Therapeutics · 19
PDF
Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severity
2014 · Christopher S. Ambrose, Xionghua Wu, et al. · Vaccine · 16
PDF
Insurance Status and the Risk of Severe Respiratory Syncytial Virus Disease in United States Preterm Infants Born at 32–35 Weeks Gestational Age
2016 · Jeremy A. Franklin, Evan J. Anderson, et al. · Open Forum Infectious Diseases · 14
PDF
Final analysis of stage 1 data from a randomized phase II study of PEGPH20 plus nab-Paclitaxel/gemcitabine in stage IV previously untreated pancreatic cancer patients (pts), utilizing Ventana companion diagnostic assay.
2016 · Andrea J. Bullock, Sunil R. Hingorani, et al. · Journal of Clinical Oncology · 12
An integrated multi-study analysis of serum HAI antibody responses to Ann Arbor strain live attenuated influenza vaccine in children and adults
2014 · Kathleen L. Coelingh, Xionghua W. Wu, et al. · Trials in Vaccinology · 8
PDF
Assessing Rates of Hypoglycemia as an End Point in Clinical Trials
2015 · Douglas B. Muchmore, Lutz Heinemann, et al. · Diabetes Care · 5
Works count: 34
Citation count: 1,441
H-index: 19
I10-index: 23
Year
Topic
Type